Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRACTICAL Platform Trial
NCT05440851Phase 3Recruiting
- Sponsor
- University Health Network
- Start
- Apr 2023
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 10
01
Overview
Phase 3, randomised, open-label trial of dexamethasone, fludrocortisone and furosemide in acute hypoxemic respiratory failure (AHRF) (21 arms), sponsored by University Health Network. Primary endpoints: Feasibility of recruiting 100 patients at 2 years, Ventilator-free days to day 28 and 8 more. Started Apr 2023; status: recruiting.
02
Drugs
dexamethasonefludrocortisonefurosemide
03
Conditions
acute hypoxemic respiratory failure (AHRF)
Beyond the preview
Go deeper on NCT05440851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05440851.